Reports
Reports
Sale
The global transplant diagnostics market size was valued at USD 3.7 billion in 2023. The market is expected to grow at a CAGR of 14.8% during the forecast period of 2024-2032 and estimated to attain a value of USD 6.8 billion by 2032. It is likely to be driven by the increasing advancements in healthcare technology, rising incidence of chronic diseases necessitating organ transplants, and the growing awareness and acceptance of transplant procedures as a viable treatment option across the globe.
Report Attribute | Key Statistics |
Base Year | 2023 |
Forecast Years | 2024-2032 |
Historical Years | 2017-2023 |
Market Size in 2023 | USD 3.7 billion |
Market Forecast in 2032 | USD 6.8 billion |
Market Growth Rate (2024-2032) | 14.8% |
Conversely, the market also presents numerous opportunities, particularly in the development of innovative diagnostic technologies that could further improve transplant success rates. There is also potential for growth in emerging markets, where increasing healthcare expenditure and infrastructure improvements can facilitate transplant diagnostics market expansion. Collaboration between governments, healthcare providers, and private sector players could address some of the existing challenges, creating a more conducive environment for market growth.
Technological Advancements
There's a significant shift towards more sophisticated diagnostic solutions, including next-generation sequencing (NGS) and molecular assays, which offer high sensitivity and specificity. These technologies enable more precise matching between donors and recipients, reduce the risk of transplant rejection, and improve patient outcomes.
Personalized Medicine and Precision Diagnostics
The market is increasingly embracing personalized medicine approaches, tailoring transplant diagnostics to individual genetic profiles. This trend is driven by the understanding that genetic compatibility plays a crucial role in the success of transplant procedures, thereby reducing the incidence of complications and improving long-term survival rates.
Expansion of Applications
Beyond traditional organ transplants, there's a growing application of transplant diagnostics in stem cell therapy, bone marrow transplantation, and other emerging areas. This expansion is facilitated by the broadening capabilities of diagnostic technologies to support a wider range of transplant types.
Automation and Integration
Laboratories and diagnostic centers are adopting automated platforms and integrated systems that streamline the diagnostic process, enhance throughput, and reduce the potential for errors. This trend towards automation also addresses the growing transplant diagnostics market demand by improving operational efficiency.
Regulatory and Reimbursement Landscape Changes
The market is influenced by evolving regulatory policies and reimbursement scenarios, which can impact the adoption of new diagnostic tests and technologies. Positive regulatory developments and supportive reimbursement policies are critical drivers for the adoption of advanced diagnostic solutions in the transplant field.
Growing Focus on Immune System Monitoring
There's an increasing emphasis on monitoring the immune system's response to transplants, aiming to detect early signs of rejection. This involves the use of biomarkers and other diagnostic tools to assess immune function and tailor immunosuppressive therapy accordingly.
Rising Demand in Emerging Markets
Emerging economies are witnessing a surge in demand for transplant diagnostics, driven by improving healthcare infrastructure, increased healthcare spending, and growing awareness about organ transplantation. This trend represents a significant growth opportunity for market players.
The global transplant diagnostics market is segmented based on product and services, technology, application, and end user, each playing a distinct role in shaping the market dynamics and influencing its trajectory in the forecast period.
Market Breakup by Product and Services
The reagents and consumables segment is foundational to transplant diagnostics, encompassing all the necessary materials for conducting tests, including but not limited to, antibodies, primers, probes, and enzymes. Given the repetitive nature of diagnostic tests and the need for high accuracy and reliability, the demand for reagents and consumables is consistently high. Their critical role in the accuracy and efficiency of diagnostic procedures means that advancements in reagents and consumables directly translate to improvements in transplant outcomes. Innovations aimed at increasing sensitivity, specificity, and reducing cross-reactivity are expected to drive the segment's impact on the transplant diagnostics market size.
Instruments are the hardware used to carry out diagnostic tests, ranging from simple devices for manual testing to sophisticated automated systems that can handle multiple samples simultaneously. The evolution of this segment towards more integrated and automated solutions reflects the market's demand for higher throughput, reduced errors, and greater efficiency in diagnostics. Instruments that offer faster turnaround times, higher precision, and compatibility with a range of tests are particularly influential in the market, enabling laboratories to scale up their operations to meet increasing transplant diagnostics market demand.
The software and services segment includes the software solutions for data analysis and interpretation, as well as the services related to transplant diagnostics, such as consulting, training, and maintenance services. As transplant diagnostics become more complex, incorporating large datasets and requiring detailed analysis, the role of software in interpreting results swiftly and accurately grows increasingly important. Moreover, services that support the effective use and maintenance of instruments and the continuous education of personnel are vital for ensuring the quality and reliability of diagnostic procedures. This segment's influence on the market is expected to grow as the integration of digital tools and AI into diagnostics deepens, facilitating more sophisticated data analysis and decision-making processes.
Each of these segments contributes uniquely to the transplant diagnostics process, and their development is closely intertwined with the overall transplant diagnostics market growth. Innovations in reagents and consumables, advancements in instrument technology, and the integration of software and comprehensive services are collectively driving the market forward, enhancing the efficiency, accuracy, and accessibility of transplant diagnostic procedures.
Market Breakup by Technology
Polymerase chain reaction (PCR) based assays are a cornerstone in transplant diagnostics, offering rapid and sensitive detection of genetic markers critical for donor-recipient compatibility. These assays are instrumental in identifying minute quantities of DNA or RNA, thereby facilitating early detection of potential transplant rejection and infectious diseases post-transplant. The speed, accuracy, and cost-effectiveness of PCR-based assays make them a preferred choice in many settings, significantly influencing the market by enabling widespread adoption across various healthcare facilities.
Sequencing-based molecular assays segment includes next-generation sequencing (NGS) and Sanger sequencing, among others, offering high-throughput, comprehensive analysis of genetic variations. Sequencing-based assays provide a deeper insight into the genetic compatibility between donors and recipients, including the identification of HLA typing, which is crucial for transplant success. The ability of these assays to deliver detailed genetic information is expected to drive their adoption, particularly in complex cases where a high degree of matching precision is necessary. As sequencing technologies continue to advance and become more cost-effective, their impact on the transplant diagnostics market value is anticipated to grow, fostering more personalized and precise transplant diagnostics.
Non-molecular assays encompass serological and other immunoassay-based techniques used to detect antibodies and antigens without the need for genetic material amplification. While these assays offer valuable information on immune status and compatibility, their use is generally more limited compared to molecular assays due to lower sensitivity and specificity. However, non-molecular assays continue to hold importance in certain contexts and for specific applications where rapid screening is essential, albeit with a gradually diminishing market impact as molecular technologies gain prominence.
During the forecast period, molecular assay technologies, particularly PCR-based and sequencing-based assays, are expected to dominate the transplant diagnostics market share. Their influence will be driven by ongoing advancements in genetic analysis, the growing emphasis on personalized medicine, and the increasing need for high-precision diagnostics. As healthcare providers and patients alike seek more accurate, efficient, and cost-effective diagnostic solutions, the adoption of molecular assays is poised to rise, further propelled by technological innovations and improvements in sequencing speed and costs. This trend underscores the shifting dynamics within the transplant diagnostics market, where molecular technologies play a central role in enabling more successful transplant outcomes and patient care advancements.
Market Breakup by Application
The global transplant diagnostics market can be segmented based on application into diagnostic applications, post-transplantation diagnostics, and research applications. Each of these segments addresses specific needs within the transplant process, from pre-transplant compatibility testing to post-transplant monitoring and research-oriented applications, significantly impacting the market's dynamics.
Diagnostic applications are pivotal to the transplant diagnostics market value, encompassing pre-transplantation diagnostics, infectious disease testing, histocompatibility testing, and blood profiling. Pre-transplantation diagnostics are crucial for assessing the suitability of both donors and recipients before the transplant, including determining organ compatibility and the recipient's health status to undergo transplantation. Infectious disease testing is essential to ensure that both the donor and recipient are free from infections that could impact transplant outcomes. Histocompatibility testing, including HLA typing, is vital for matching donors and recipients to minimize the risk of transplant rejection. Blood profiling involves analyzing blood groups and other markers to further ensure compatibility and guide the selection of immunosuppressive regimens. Collectively, these diagnostic applications are foundational to the transplant process, ensuring that transplants are performed safely and with the highest chance of success.
Post-transplantation diagnostics focus on monitoring the recipient after the transplant has occurred. This includes detecting signs of organ rejection, monitoring the organ's function, and identifying any infectious complications that may arise. The importance of post-transplantation diagnostics lies in their ability to provide early detection of issues, allowing for timely interventions that can significantly improve patient outcomes and prolong the life of the transplant.
Research applications in the transplant diagnostics market are centered on advancing the field through the development of new diagnostic tools, techniques, and technologies. This segment is crucial for improving understanding of transplant immunology, developing more precise diagnostics, and ultimately enhancing the success rates of transplant procedures. Research applications drive innovation in the market, with potential impacts ranging from the discovery of novel biomarkers to the development of next-generation sequencing technologies for more accurate compatibility testing.
Looking forward, diagnostic applications are expected to continue influencing the market significantly in the forecast period. As the demand for transplants grows and the complexity of transplant procedures increases, the need for comprehensive diagnostic testing before transplantation will become even more critical. Advancements in diagnostics technology, such as more precise histocompatibility testing and infectious disease screening, are likely to enhance the efficiency and success rates of transplants. This, in turn, will drive demand for diagnostic applications, ensuring their continued impact on the transplant diagnostics market growth and development.
Market Breakup by Transplant Type
The market can be segmented based on transplant type into several key categories, including solid organ transplantation, stem cell transplantation, soft tissue transplantation, and bone marrow transplantation. Each of these segments plays a crucial role in transplant diagnostics market overview, influenced by factors such as technological advancements, increasing incidence of chronic diseases, and the growing number of transplant procedures globally.
Solid organ transplantation encompasses the diagnosis before and after the transplantation of organs such as the liver, kidney, heart, and lungs. This segment is a significant contributor to the transplant diagnostics market due to the high volume of these transplant procedures and the critical need for precise matching and rejection monitoring diagnostics. The advancements in molecular assays and next-generation sequencing (NGS) technologies have greatly enhanced the success rates of solid organ transplants by ensuring better compatibility and reducing the risk of rejection.
Stem cell transplantation, involving the transplantation of hematopoietic stem cells, usually for the treatment of blood disorders and certain types of cancers, also represents a vital segment. The demand for stem cell transplantation diagnostics is driven by the need for high-resolution typing methods to achieve optimal donor-recipient matching and to monitor potential complications, such as graft-versus-host disease (GVHD).
Soft tissue transplantation includes the transplantation of tissues such as skin, corneas, and heart valves. Although this segment involves a wide range of transplant types, the common denominator is the requirement for effective diagnostic tools to assess the viability and compatibility of soft tissues, which is crucial for the success of these procedures.
Bone marrow transplantation is closely related to stem cell transplantation but is specifically focused on diseases affecting the bone marrow. The diagnostics for this segment are centered around ensuring the compatibility of donor and recipient, as well as monitoring the patient's response to the transplant. This segment's growth is propelled by the increasing prevalence of hematological diseases and the continuous improvement in genetic testing technologies.
Each of these segments is expected to influence the global transplant diagnostics market differently in the forecast period. Factors such as the increasing accessibility to advanced diagnostic technologies, the expansion of transplant registries, and the growing awareness of transplantation as a viable treatment option are likely to drive the market forward. Innovations in genomics and personalized medicine are also anticipated to enhance the efficiency and outcomes of transplant diagnostics, further contributing to the market's growth across all segments.
Market Breakup by End User
The global transplant diagnostics market can be segmented based on end users into several categories, including Reference Laboratories, Hospitals and Transplant Centers, Research Laboratories and Academic Institutes, and Others. Each segment has a distinct role and impact on the market, driven by the specific needs and services they provide within the transplant diagnostics landscape.
Reference laboratories play a pivotal role in the transplant diagnostics market share, owing to their specialized capabilities in performing a wide range of complex tests. These laboratories are equipped with advanced diagnostic technologies and staffed by experts in the field, making them critical for the accurate typing, crossmatching, and antibody screening required for transplant compatibility and post-transplant monitoring. Their ability to offer high-throughput and specialized testing services makes them an essential component of the diagnostics chain, contributing significantly to the market's dynamics.
Hospitals and transplant centers are directly involved in the patient care pathway, from pre-transplant evaluation to post-transplant monitoring. This segment's impact on the transplant diagnostics market is substantial, as these institutions are the primary sites where transplants are performed and where immediate diagnostic services are required. The integration of diagnostic services in these settings facilitates timely decision-making, enhancing patient outcomes and operational efficiencies.
Research laboratories and academic institutes contribute to the transplant diagnostics market through their focus on innovation, research, and development of new diagnostic methodologies. This segment is crucial for the advancement of transplant diagnostics, as it drives the discovery and implementation of novel diagnostic markers, techniques, and technologies. Their work not only impacts the current market by improving diagnostic accuracy and patient outcomes but also shapes the future of transplant diagnostics through ongoing research endeavors.
During the forecast period, the hospitals and transplant centers segment is expected to have a significant influence on the transplant diagnostics market value. The increasing number of transplant procedures globally, coupled with the growing emphasis on personalized medicine and patient-centered care, is likely to drive demand for integrated and advanced diagnostic services within these settings. The push towards improving transplant outcomes and reducing rejection rates will further necessitate the adoption of cutting-edge diagnostic solutions in hospitals and transplant centers, making this segment a critical driver of market growth.
Market Breakup by Region
North America is a leading region in the transplant diagnostics market share, primarily due to the advanced healthcare infrastructure, high healthcare expenditure, and the presence of key market players. The region's focus on research and development activities, coupled with a high rate of organ transplantation procedures, significantly contributes to its dominant position. North America's emphasis on adopting innovative technologies and the strong support from government policies for organ transplantation are expected to continue driving the market's growth in the forecast period.
Europe follows closely, with a well-established healthcare system and increasing awareness regarding the benefits of organ transplantation. The region benefits from favorable government policies, advanced healthcare facilities, and significant investment in healthcare research. Europe's strong network of organ donation and transplantation organizations plays a vital role in facilitating organ transplants, which in turn, boosts transplant diagnostics market demand.
Asia Pacific is anticipated to witness rapid transplant diagnostics market growth due to the expanding healthcare infrastructure, rising healthcare expenditure, and growing awareness about organ transplantation. The region's large population base, coupled with increasing incidences of chronic diseases requiring organ transplantation, is expected to fuel the market growth. Furthermore, government initiatives aimed at improving healthcare access and the increasing adoption of advanced diagnostic technologies are likely to propel the market in Asia Pacific.
Latin America and the Middle East and Africa are regions with potential for growth in the transplant diagnostics market. These regions are gradually witnessing improvements in healthcare infrastructure and an increase in the number of organ transplantation procedures. The growing awareness about the benefits of organ transplantation, coupled with government efforts to establish organ donation and transplantation frameworks, are factors expected to influence the market positively. However, these regions face challenges such as limited access to advanced healthcare facilities and a shortage of skilled healthcare professionals, which might affect the market growth rate.
The competitive landscape of the global transplant diagnostics market is characterized by its dynamic and innovative nature, with several key factors influencing the competitive dynamics. This landscape comprises a mix of established players and emerging companies, each contributing to the advancements and technological progress in the field of transplant diagnostics. The competitive environment is shaped by various factors, including technological innovations, regulatory policies, market demand, and strategic initiatives undertaken by companies.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Unit | USD Billion |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Product and Services Covered |
|
Technology Covered |
|
Application Covered |
|
Transplant Type Covered |
|
End User Covered |
|
Regions Covered |
|
Countries Covered |
|
Companies Covered |
|
Customization Scope | 10% Free Customization |
Customization Scope |
|
Report Price and Purchase Option | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Transplant Diagnostics Market Overview
3.1 Global Transplant Diagnostics Market Historical Value (2017-2023)
3.2 Global Transplant Diagnostics Market Forecast Value (2024-2032)
4 Global Transplant Diagnostics Market Landscape*
4.1 Global Transplant Diagnostics: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Transplant Diagnostics: Product Landscape
4.2.1 Analysis by Product & Services
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
5 Global Transplant Diagnostics Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Transplant Diagnostics Market Segmentation (2017-2032)
6.1 Global Transplant Diagnostics Market (2017-2032) by Product and Services
6.1.1 Market Overview
6.1.2 Reagent and Consumables
6.1.3 Instruments
6.1.4 Software and Services
6.2 Global Transplant Diagnostics Market (2017-2032) by Technology
6.2.1 Market Overview
6.2.2 Molecular Assay
6.2.2.1 PCR Based Molecular Assays
6.2.2.1.1 Sequence Specific Oligonucleotide PCR
6.2.2.1.2 Sequence Specific Primer PCR
6.2.2.1.3 Real-time PCR
6.2.2.1.4 Other PCR based Molecular Assays.
6.2.2.2 Sequencing Based Molecular Assays
6.2.2.2.1 Sanger Sequencing
6.2.2.2.2 Next Generation Sequencing
6.2.2.2.3 Other Sequencing based Molecular Assay
6.2.3 Non-molecular Assay
6.3 Global Transplant Diagnostics Market (2017-2032) by Application
6.3.1 Market Overview
6.3.2 Diagnostics Applications
6.3.2.1 Pre-transplantation Diagnostics
6.3.2.1.1 Infectious Disease Testing
6.3.2.1.2 Histocompatibility Testing
6.3.2.1.3 Blood Profiling
6.3.2.2 Post-transplantation Diagnostics
6.3.3 Research Applications
6.4 Global Transplant Diagnostics Market (2017-2032) by Transplant Type
6.4.1 Market Overview
6.4.2 Solid Organ Transplantation
6.4.3 Stem Cell Transplantation
6.4.4 Soft Tissue Transplantation
6.4.5 Bone Marrow Transplantation
6.5 Global Transplant Diagnostics Market (2017-2032) by End User
6.5.1 Market Overview
6.5.2 Reference Laboratories
6.5.3 Hospital and Transplant Centers
6.5.4 Research Laboratories and Academic Institutes
6.5.5 Others
6.6 Global Transplant Diagnostics Market (2017-2032) by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Transplant Diagnostics Market (2017-2032)
7.1 North America Transplant Diagnostics Market (2017-2032) by Product and Services
7.1.1 Market Overview
7.1.2 Reagent and Consumables
7.1.3 Instruments
7.1.4 Software and Services
7.2 North America Transplant Diagnostics Market (2017-2032) by Application
7.2.1 Market Overview
7.2.2 Diagnostics Applications
7.2.2.1 Pre-transplantation Diagnostics
7.2.2.1.1 Infectious Disease Testing
7.2.2.1.2 Histocompatibility Testing
7.2.2.1.3 Blood Profiling
7.2.2.2 Post-transplantation Diagnostics
7.2.3 Research Applications
7.3 North America Transplant Diagnostics Market (2017-2032) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe Transplant Diagnostics Market (2017-2032)
8.1 Europe Transplant Diagnostics Market (2017-2032) by Product and Services
8.1.1 Market Overview
8.1.2 Reagent and Consumables
8.1.3 Instruments
8.1.4 Software and Services
8.2 Europe Transplant Diagnostics Market (2017-2032) by Application
8.2.1 Market Overview
8.2.2 Diagnostics Applications
8.2.2.1 Pre-transplantation Diagnostics
8.2.2.1.1 Infectious Disease Testing
8.2.2.1.2 Histocompatibility Testing
8.2.2.1.3 Blood Profiling
8.2.2.2 Post-transplantation Diagnostics
8.2.3 Research Applications
8.3 Europe Transplant Diagnostics Market (2017-2032) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Others
9 Asia Pacific Transplant Diagnostics Market (2017-2032)
9.1 Asia Pacific Transplant Diagnostics Market (2017-2032) by Product and Services
9.1.1 Market Overview
9.1.2 Reagent and Consumables
9.1.3 Instruments
9.1.4 Software and Services
9.2 Asia Pacific Transplant Diagnostics Market (2017-2032) by Application
9.2.1 Market Overview
9.2.2 Diagnostics Applications
9.2.2.1 Pre-transplantation Diagnostics
9.2.2.1.1 Infectious Disease Testing
9.2.2.1.2 Histocompatibility Testing
9.2.2.1.3 Blood Profiling
9.2.2.2 Post-transplantation Diagnostics
9.2.3 Research Applications
9.3 Asia Pacific Transplant Diagnostics Market (2017-2032) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 ASEAN
9.3.5 Australia
9.3.6 Others
10 Latin America Transplant Diagnostics Market (2017-2032)
10.1 Latin America Transplant Diagnostics Market (2017-2032) by Product and Services
10.1.1 Market Overview
10.1.2 Reagent and Consumables
10.1.3 Instruments
10.1.4 Software and Services
10.2 Latin America Transplant Diagnostics Market (2017-2032) by Application
10.2.1 Market Overview
10.2.2 Diagnostics Applications
10.2.2.1 Pre-transplantation Diagnostics
10.2.2.1.1 Infectious Disease Testing
10.2.2.1.2 Histocompatibility Testing
10.2.2.1.3 Blood Profiling
10.2.2.2 Post-transplantation Diagnostics
10.2.3 Research Applications
10.3 Latin America Transplant Diagnostics Market (2017-2032) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Others
11 Middle East and Africa Transplant Diagnostics Market (2017-2032)
11.1 Middle East and Africa Transplant Diagnostics Market (2017-2032) by Product and Services
11.1.1 Market Overview
11.1.2 Reagent and Consumables
11.1.3 Instruments
11.1.4 Software and Services
11.2 Middle East and Africa Transplant Diagnostics Market (2017-2032) by Application
11.2.1 Market Overview
11.2.2 Diagnostics Applications
11.2.2.1 Pre-transplantation Diagnostics
11.2.2.1.1 Infectious Disease Testing
11.2.2.1.2 Histocompatibility Testing
11.2.2.1.3 Blood Profiling
11.2.2.2 Post-transplantation Diagnostics
11.2.3 Research Applications
11.3 Middle East and Africa Transplant Diagnostics Market (2017-2032) by Country
11.3.1 Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Nigeria
11.3.4 South Africa
11.3.5 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Bio-Rad Laboratories Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Abbott Laboratories
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Becton, Dickinson and Company
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Biomérieux SA
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 CareDx
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 F Hoffman-La Roche AG
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Hologic Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Illumina Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Qiagen NV
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Thermo Fisher Scientific Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Immucor, Inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Omixon Ltd.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 GenDx
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 BioGenuix
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
List not exhaustive
18 Global Transplant Diagnostics Market – Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.